Newcells Biotech Overview

  • Founded

  • 2014

Founded
  • Status

  • Private

  • Employees

  • 42

Employees
  • Latest Deal Type

  • Later Stage VC

  • Latest Deal Amount

  • $7.24M

  • Investors

  • 4

Newcells Biotech General Information

Description

Developer of a biotechnology platform intended to develop in vitro cell-based assays for early drug discovery and development. The company's platform is focused on building models that closely mimic the physiology of the kidney, retina, liver, and lung that improve prediction of safety, pharmacology, and efficacy in humans and commercialized kidney and retina platforms as best in class and development for launch stem cell-based models of the liver and lung, enabling researchers to research and test new drugs and screen potential drug molecules for efficacy and toxicity.

Contact Information

Website
www.newcellsbiotech.co.uk
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Primary Office
  • The Biosphere, Drayman's Way
  • Newcastle Helix
  • Newcastle Upon Tyne NE4 5BX
  • England, United Kingdom
+44 0191 000 0000

Newcells Biotech Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Newcells Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 23-Feb-2021 $7.24M 000.00 000.00 Completed Generating Revenue
5. Grant 01-Oct-2019 00000 00.000 Completed Generating Revenue
4. Early Stage VC 04-Jul-2018 00.000 00.000 00.000 Completed Generating Revenue
3. Grant 22-Aug-2017 00.000 00000 Completed Generating Revenue
2. Grant 01-Oct-2016 $1.05M $239K Completed Generating Revenue
1. Seed Round 02-Sep-2015 $239K $239K 00.000 Completed Generating Revenue
To view Newcells Biotech’s complete valuation and funding history, request access »

Newcells Biotech Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
F2 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
F1 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
E Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
F2 Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.00
F1 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
E Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
D2 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
D1 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
C Ordinary 337,969 $0.000138 $2.04 $2.04 1x $2.04 6.67%
Ordinary A 29,500 $0.000138 $7.18 $7.18 1x $7.18 0.58%
To view Newcells Biotech’s complete cap table history, request access »

Newcells Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a biotechnology platform intended to develop in vitro cell-based assays for early drug discovery and develo
Drug Discovery
Newcastle Upon Tyne, United Kingdom
42 As of 2022
000.00
00.00 0000-00-00
0000000000 0 000.00

000000

ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labori
00000 000000000000000 000 0000000000000
Hicksville, NY
000 As of 0000
000000000000

0000 0

sectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
0000000000000
Midlothian, VA
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Newcells Biotech Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioIVT Private Equity-Backed Hicksville, NY 000 000000000000
0000 0000000000 Venture Capital-Backed Midlothian, VA 00 000.00 0000000000 0 000.00
000000000 Venture Capital-Backed Cambridge, United Kingdom 00 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed South San Francisco, CA 00 000.00 0000000000 000.00
0000000 Formerly VC-backed Leuven, Belgium 00 00000 000000&0 00000
You’re viewing 5 of 24 competitors. Get the full list »

Newcells Biotech Patents

  • 21

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

Newcells Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202204371-D0 Fluid flow plate Pending 28-Mar-2022
GB-202112237-D0 Fluid flow plate Pending 26-Aug-2021
GB-201913923-D0 A method for obtaining pluripotent stem cell-derived airway basal-like cells and an airway epithelium model Pending 26-Sep-2019 0000000000
US-20220340880-A1 A method for obtaining pluripotent stem cell-derived airway basal-like cells and an airway epithelium model Pending 26-Sep-2019 0000000000
GB-2587802-A A method for obtaining pluripotent stem cell-derived airway basal-like cells and an airway epithelium model Pending 26-Sep-2019 C12N5/0689
To view Newcells Biotech’s complete patent history, request access »

Newcells Biotech Executive Team (6)

Name Title Board Seat Contact Info
Michael Nicholds Co-Founder, Chief Executive Officer & Board Member
Lyle Armstrong Ph.D Co-Founder, Chief Scientific Officer & Board Member
Simon Berry Finance Director
David Hutchings Ph.D Chief Commercial Officer
Colin Brown Chief Innovation Officer
You’re viewing 5 of 6 executive team members. Get the full list »

Newcells Biotech Board Members (5)

Name Representing Role Since
Frank Armstrong MD Self Board Member 000 0000
Lyle Armstrong Ph.D Newcells Biotech Co-Founder, Chief Scientific Officer & Board Member 000 0000
Michael Nicholds Newcells Biotech Co-Founder, Chief Executive Officer & Board Member 000 0000
Sandy Primrose Self Board Member 000 0000
Timothy Levett NVM Private Equity Board Member 000 0000
To view Newcells Biotech’s complete board members history, request access »

Newcells Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Newcells Biotech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mercia Asset Management Venture Capital Minority 000 0000 000000 0
NVM Private Equity PE/Buyout Minority 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
Northstar Ventures Venture Capital Minority 000 0000 000000 0
To view Newcells Biotech’s complete investors history, request access »

Ready to get started?

Request a free trial